Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Jan 9;93(1):1–6. doi: 10.1073/pnas.93.1.1

Binding in the growth hormone receptor complex.

J A Wells 1
PMCID: PMC40168  PMID: 8552582

Abstract

Binding reactions between human growth hormone (hGH) and its receptor provide a detailed account of how a polypeptide hormone activates its receptor and more generally how proteins interact. Through high-resolution structural and functional studies it is seen that hGH uses two different sites (site 1 and site 2) to bind two identical receptor molecules. This sequential dimerization reaction activates the receptor, presumably by bringing the intracellular domains into close proximity so they may activate cytosolic components. As a consequence of this mechanism it is possible to build antagonists to the receptor by introducing mutations in hGH that block binding at site 2 and to build even more potent antagonists by combining these with mutants that enhance binding at site 1. Alanine-scanning mutagenesis of all contact residues at the site 1 interface shows that only a small and complementary set of side chains clustered near the center of the interface affects binding. The most important contacts are hydrophobic, and these are surrounded by polar and charged interactions of lesser importance. Kinetic analysis shows for the most part that the important side chains function to maintain the complex, not to guide the hormone to the receptor. Hormone-induced homodimerization or heterodimerization reactions are turning out to be pervasive mechanisms for signal transduction. Moreover, the molecular recognition principles seen in the hGH-receptor complex are likely to generalize to other protein-protein complexes.

Full text

PDF
1

Images in this article

2Fig. 1
on p.2
4Fig. 2
on p.4
5Fig. 3
on p.5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altmann S. W., Kastelein R. A. Rational design of a mouse granulocyte macrophage-colony-stimulating factor receptor antagonist. J Biol Chem. 1995 Feb 3;270(5):2233–2240. doi: 10.1074/jbc.270.5.2233. [DOI] [PubMed] [Google Scholar]
  2. Barnard R., Bundesen P. G., Rylatt D. B., Waters M. J. Monoclonal antibodies to the rabbit liver growth hormone receptor: production and characterization. Endocrinology. 1984 Nov;115(5):1805–1813. doi: 10.1210/endo-115-5-1805. [DOI] [PubMed] [Google Scholar]
  3. Bass S. H., Mulkerrin M. G., Wells J. A. A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4498–4502. doi: 10.1073/pnas.88.10.4498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A. 1990 Sep;87(18):6934–6938. doi: 10.1073/pnas.87.18.6934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boutin J. M., Edery M., Shirota M., Jolicoeur C., Lesueur L., Ali S., Gould D., Djiane J., Kelly P. A. Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol Endocrinol. 1989 Sep;3(9):1455–1461. doi: 10.1210/mend-3-9-1455. [DOI] [PubMed] [Google Scholar]
  6. Chang C. N., Rey M., Bochner B., Heyneker H., Gray G. High-level secretion of human growth hormone by Escherichia coli. Gene. 1987;55(2-3):189–196. doi: 10.1016/0378-1119(87)90279-4. [DOI] [PubMed] [Google Scholar]
  7. Chen W. Y., Wight D. C., Mehta B. V., Wagner T. E., Kopchick J. J. Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Mol Endocrinol. 1991 Dec;5(12):1845–1852. doi: 10.1210/mend-5-12-1845. [DOI] [PubMed] [Google Scholar]
  8. Clackson T., Wells J. A. A hot spot of binding energy in a hormone-receptor interface. Science. 1995 Jan 20;267(5196):383–386. doi: 10.1126/science.7529940. [DOI] [PubMed] [Google Scholar]
  9. Cunningham B. C., Jhurani P., Ng P., Wells J. A. Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science. 1989 Mar 10;243(4896):1330–1336. doi: 10.1126/science.2466339. [DOI] [PubMed] [Google Scholar]
  10. Cunningham B. C., Ultsch M., De Vos A. M., Mulkerrin M. G., Clauser K. R., Wells J. A. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science. 1991 Nov 8;254(5033):821–825. doi: 10.1126/science.1948064. [DOI] [PubMed] [Google Scholar]
  11. Cunningham B. C., Wells J. A. Comparison of a structural and a functional epitope. J Mol Biol. 1993 Dec 5;234(3):554–563. doi: 10.1006/jmbi.1993.1611. [DOI] [PubMed] [Google Scholar]
  12. Cunningham B. C., Wells J. A. High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science. 1989 Jun 2;244(4908):1081–1085. doi: 10.1126/science.2471267. [DOI] [PubMed] [Google Scholar]
  13. Davies D. R., Cohen G. H. Interactions of protein antigens with antibodies. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):7–12. doi: 10.1073/pnas.93.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fuh G., Colosi P., Wood W. I., Wells J. A. Mechanism-based design of prolactin receptor antagonists. J Biol Chem. 1993 Mar 15;268(8):5376–5381. [PubMed] [Google Scholar]
  15. Fuh G., Cunningham B. C., Fukunaga R., Nagata S., Goeddel D. V., Wells J. A. Rational design of potent antagonists to the human growth hormone receptor. Science. 1992 Jun 19;256(5064):1677–1680. doi: 10.1126/science.256.5064.1677. [DOI] [PubMed] [Google Scholar]
  16. Fuh G., Mulkerrin M. G., Bass S., McFarland N., Brochier M., Bourell J. H., Light D. R., Wells J. A. The human growth hormone receptor. Secretion from Escherichia coli and disulfide bonding pattern of the extracellular binding domain. J Biol Chem. 1990 Feb 25;265(6):3111–3115. [PubMed] [Google Scholar]
  17. Ilondo M. M., Damholt A. B., Cunningham B. A., Wells J. A., De Meyts P., Shymko R. M. Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes. Endocrinology. 1994 Jun;134(6):2397–2403. doi: 10.1210/endo.134.6.8194466. [DOI] [PubMed] [Google Scholar]
  18. Imler J. L., Zurawski G. Receptor binding and internalization of mouse interleukin-2 derivatives that are partial agonists. J Biol Chem. 1992 Jul 5;267(19):13185–13190. [PubMed] [Google Scholar]
  19. Isaksson O. G., Edén S., Jansson J. O. Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol. 1985;47:483–499. doi: 10.1146/annurev.ph.47.030185.002411. [DOI] [PubMed] [Google Scholar]
  20. Jones S., Thornton J. M. Principles of protein-protein interactions. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):13–20. doi: 10.1073/pnas.93.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Karlsson R., Michaelsson A., Mattsson L. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J Immunol Methods. 1991 Dec 15;145(1-2):229–240. doi: 10.1016/0022-1759(91)90331-9. [DOI] [PubMed] [Google Scholar]
  22. Kossiakoff A. A., Somers W., Ultsch M., Andow K., Muller Y. A., De Vos A. M. Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors. Protein Sci. 1994 Oct;3(10):1697–1705. doi: 10.1002/pro.5560031008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kruse N., Shen B. J., Arnold S., Tony H. P., Müller T., Sebald W. Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. EMBO J. 1993 Dec 15;12(13):5121–5129. doi: 10.1002/j.1460-2075.1993.tb06207.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Leung D. W., Spencer S. A., Cachianes G., Hammonds R. G., Collins C., Henzel W. J., Barnard R., Waters M. J., Wood W. I. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature. 1987 Dec 10;330(6148):537–543. doi: 10.1038/330537a0. [DOI] [PubMed] [Google Scholar]
  25. Lokker N. A., Zenke G., Strittmatter U., Fagg B., Movva N. R. Structure-activity relationship study of human interleukin-3: role of the C-terminal region for biological activity. EMBO J. 1991 Aug;10(8):2125–2131. doi: 10.1002/j.1460-2075.1991.tb07746.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lopez A. F., Shannon M. F., Barry S., Phillips J. A., Cambareri B., Dottore M., Simmons P., Vadas M. A. A human interleukin 3 analog with increased biological and binding activities. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11842–11846. doi: 10.1073/pnas.89.24.11842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Northrup S. H., Erickson H. P. Kinetics of protein-protein association explained by Brownian dynamics computer simulation. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3338–3342. doi: 10.1073/pnas.89.8.3338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Savino R., Lahm A., Salvati A. L., Ciapponi L., Sporeno E., Altamura S., Paonessa G., Toniatti C., Ciliberto G. Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation. EMBO J. 1994 Mar 15;13(6):1357–1367. doi: 10.1002/j.1460-2075.1994.tb06389.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Shanafelt A. B., Miyajima A., Kitamura T., Kastelein R. A. The amino-terminal helix of GM-CSF and IL-5 governs high affinity binding to their receptors. EMBO J. 1991 Dec;10(13):4105–4112. doi: 10.1002/j.1460-2075.1991.tb04987.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Silva C. M., Weber M. J., Thorner M. O. Stimulation of tyrosine phosphorylation in human cells by activation of the growth hormone receptor. Endocrinology. 1993 Jan;132(1):101–108. doi: 10.1210/endo.132.1.7678212. [DOI] [PubMed] [Google Scholar]
  31. Stahl N., Yancopoulos G. D. The alphas, betas, and kinases of cytokine receptor complexes. Cell. 1993 Aug 27;74(4):587–590. doi: 10.1016/0092-8674(93)90506-l. [DOI] [PubMed] [Google Scholar]
  32. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990 Apr 20;61(2):203–212. doi: 10.1016/0092-8674(90)90801-k. [DOI] [PubMed] [Google Scholar]
  33. Ultsch M., de Vos A. M., Kossiakoff A. A. Crystals of the complex between human growth hormone and the extracellular domain of its receptor. J Mol Biol. 1991 Dec 20;222(4):865–868. doi: 10.1016/0022-2836(91)90578-t. [DOI] [PubMed] [Google Scholar]
  34. Wells J. A. Structural and functional basis for hormone binding and receptor oligomerization. Curr Opin Cell Biol. 1994 Apr;6(2):163–173. doi: 10.1016/0955-0674(94)90132-5. [DOI] [PubMed] [Google Scholar]
  35. Wells J. A. Systematic mutational analyses of protein-protein interfaces. Methods Enzymol. 1991;202:390–411. doi: 10.1016/0076-6879(91)02020-a. [DOI] [PubMed] [Google Scholar]
  36. Wells J. A., de Vos A. M. Structure and function of human growth hormone: implications for the hematopoietins. Annu Rev Biophys Biomol Struct. 1993;22:329–351. doi: 10.1146/annurev.bb.22.060193.001553. [DOI] [PubMed] [Google Scholar]
  37. de Vos A. M., Ultsch M., Kossiakoff A. A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 1992 Jan 17;255(5042):306–312. doi: 10.1126/science.1549776. [DOI] [PubMed] [Google Scholar]
  38. von Hippel P. H., Berg O. G. Facilitated target location in biological systems. J Biol Chem. 1989 Jan 15;264(2):675–678. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES